NCT00393809View on ClinicalTrials.gov

Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions
Bladder Neoplasms
Interventions
DRUG

DTA-H19

Trial Locations (2)

Unknown

E. Wolfson Medical Center, Holon

Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
collaborator

Anchiano Therapeutics Israel Ltd.

INDUSTRY

lead

Hebrew University of Jerusalem

OTHER

NCT00393809 - Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer | Biotech Hunter | Biotech Hunter